The tool is based on distinct molecular tumor features identified by The Cancer Genome Atlas Network, according to a Jan. 2 news release from the institute.
Researchers published a paper describing the resource in Cancer Cell, and outlined how it can be used for clinical implementation.
The resource was developed with TCGA data from 8,791 cancer samples from 26 cohorts and 106 subtypes to establish 737 ready-to-use models for clinicians to use for cancer subtype prediction and diagnosis, the release said.
The tool can be accessed online here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
